Cargando…
Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the novel coronavirus, causing coronavirus disease 2019 (COVID-19). During virus infection, several pro-inflammatory cytokines are produced, leading to the “cytokine storm.” Among these, interleukin (IL)-6, tumor necrosis factor‐α (TNF‐...
Autores principales: | Vomero, Marta, Barbati, Cristiana, Colasanti, Tania, Celia, Alessandra Ida, Speziali, Mariangela, Ucci, Federica Maria, Ciancarella, Claudia, Conti, Fabrizio, Alessandri, Cristiano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794008/ https://www.ncbi.nlm.nih.gov/pubmed/33424586 http://dx.doi.org/10.3389/fphar.2020.569849 |
Ejemplares similares
-
Autophagy Hijacking in PBMC From COVID-19 Patients Results in Lymphopenia
por: Barbati, Cristiana, et al.
Publicado: (2022) -
Tofacitinib Decreases Autophagy of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients
por: Vomero, M., et al.
Publicado: (2022) -
Autophagy in Rheumatic Diseases: Role in the Pathogenesis and Therapeutic Approaches
por: Celia, Alessandra Ida, et al.
Publicado: (2022) -
Belimumab Decreases Autophagy and Citrullination in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
por: Colasanti, Tania, et al.
Publicado: (2022) -
Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives
por: Vomero, Marta, et al.
Publicado: (2018)